Tag:
depression
Latest Headlines
Latest Headlines
Blood test could spot when 'baby blues' run too deep
A blood test could pick out the women who are most at risk of postnatal depression, meaning that they and their families could get the support and treatment they need at a very vulnerable time.
Lundbeck soars on PhIII success for blockbuster hopeful
Lundbeck shares spiked 9% this morning on the news that three late-stage studies of its new depression drug had delivered the data needed to support upcoming regulatory filings.
DSM panel holds firm on new autism diagnosis, ditches 2 other revisions
A panel of psychiatrists revising the Diagnostic and Statistical Manual of Mental Disorders are holding firm on their streamlined diagnosis for autism but are backing off proposals for changes to some others.
Targacept slashes staff by half in wake of PhIII disaster
The late-stage collapse of Targacept's depression drug--TC-5214--will cost the jobs of close to half of the biotech's staffers, with 65 workers getting pink slips today.
Blood genetic markers test for teen depression
Diagnosis of clinical depression is complex, but early diagnosis and more targeted treatment could improve outcomes in later life.
Supernus plots product launches as it dusts off $76M IPO attempt
Supernus Pharmaceuticals has finally dusted off the paperwork and suggested a $12 to $14 price range on some 5.8 million shares.
Aleva scores $4.4M for next-gen DBS therapy
Switzerland's Aleva Neurotherapeutics is looking to make a splash with its own next-generation implants for DBS, and it has just scored 4 million Swiss francs ($4.4 million) in Series B to advance the clinical development of its products.
Looking closely: Inflammation imaging as a depression biomarker
Does depression cause inflammation or does inflammation cause depression? There seems to be another vote for inflammation as a root cause.
New drug blocks brain cancer advance, making chemo kill easier
Invasive brain tumors are often unstoppable, and even chemotherapy drugs can't always halt their advance. That could change with a new compound.
Depression drug research goes off the rails (again)
Why do drugmakers have so much trouble developing new depression treatments?
